Molecular characterization of response to etrolizumab and anti-TNF reveals treatment resistance in ulcerative colitis is associated with the abundance of residual neutrophil subsets and inflammatory fibroblast populations
Shadi Toghi Eshghi, John Mark B. Gubatan, Parisa Mazrooei, Luis Quintanilla, Allen Nguyen, Amelia Au‐Yeung, Derek Holman, Chikara Takahashi, Courtney Schiffman, William E. O’Gorman, Mary E Keir, Saroja Ramanujan, Stephan Rogalla, Jason A. Hackney, Jacqueline McBride
The paper identifies treatment resistance in ulcerative colitis linked to residual neutrophil subsets and inflammatory fibroblasts using single-cell analysis of biopsy data.
bioRxiv · Jul 2, 2024 · PreprintImmunology